Chronic kidney disease (CKD) results in hyperphosphatemia, enhanced tubular phosphate load and increased synthesis of fibroblast growth factor 23 (FGF23), which is discussed to contribute to inflammation and disease progression [25, 26, 27, 28, 29]. The gene discussed is FGF23; the disease is hyperphosphatemia.